Rubio, Jayson D.

HRN: 09-13-77  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/12/2025
09/19/2025
IV
2.25g
Q8h
CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines